Cymabay Therapeutics Inc (CBAY.OQ)
CBAY.OQ on NASDAQ Stock Exchange Global Select Market
12.94USD
9:00pm BST
12.94USD
9:00pm BST
Change (% chg)
$0.22 (+1.73%)
$0.22 (+1.73%)
Prev Close
$12.72
$12.72
Open
$12.70
$12.70
Day's High
$13.01
$13.01
Day's Low
$12.65
$12.65
Volume
86,463
86,463
Avg. Vol
237,104
237,104
52-wk High
$15.00
$15.00
52-wk Low
$6.33
$6.33
About
CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies to treat metabolic diseases, including serious rare and orphan diseases. The Company's product candidates include Arhalofenate, MBX-8025 and MBX-2982. Arhalofenate is used to treat gout. MBX-8025 is a... (more)
Overall
| Beta: | 1.77 |
| Market Cap(Mil.): | $858.05 |
| Shares Outstanding(Mil.): | 67.46 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CBAY.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 109.42 | 62.41 |
| EPS (TTM): | -1.26 | -- | -- |
| ROI: | -55.75 | 7.98 | 11.81 |
| ROE: | -56.82 | 8.13 | 12.64 |
Estimates